MIAMI, May 3, 2011 /PRNewswire/ -- GenerationOne and Cincinnati Children's Hospital Medical Center collaborated on a 14-month clinical trial for testing mobile technology in aiding the management of teenagers with Asthma.
"Mobile phones represent an appealing technology for tailoring interventions and bridging knowledge to action in adolescents but there was limited knowledge in this area. This study will serve as a basis for efforts to secure funding for a larger clinical trial to fully test the efficacy of this intervention", said Michael Seid, PhD, principal investigator and a professor in the Division of Pulmonary Medicine and the Anderson Center for Health Systems Excellence.
Adherence is a key to asthma control, but is challenging, particularly for kids. Through this pilot, Cincinnati Children's and GenerationOne developed and tested self-management interventions for adolescents with asthma that incorporate efficacious components that were tailored, via mobile technology, to adolescent needs. The goal was to develop and pilot test a personalized multimodal behavioral intervention incorporating motivation, knowledge, and problem-solving skills to overcome barriers to adherence in adolescents with moderate and severe persistent asthma.
"Asthma continues to impose a considerable health burden on the U.S. population, especially in adolescents. GenerationOne was pleased to tailor a mobile program for Cincinnati Children's research program for testing teen's ability to use mobile devices in helping them control Asthma in real life situations," according to Jeff Wolf, Founder and CEO GenerationOne.
Subjects for the research were recruited from Cincinnati Children's Teen Health Center (THC). The GenerationOne mobile health platform was programmed with the medical content and protocols developed by Cincinnati Children's. Each participant received personalized messages and reminders via the participant's own cell phone